Transcatheter Closure of Very Large ( ≥ 25 mm) Atrial
Septal Defects Using the Amplatzer Septal Occluder
Bhava Ramalingam Jawahar Kannan, MD, Edwin Francis, MD, Kothandam Sivakumar, MD,
Sivadasan Radha Anil, MD, and Raman Krishna Kumar,
*
MD
Between June 1999 and September 2002, 45 patients (age, 34 13 years; mean shunt
ratio, 2.6 0.6) underwent transcatheter atrial septal defect (ASD) closure at our insti-
tution with the Amplatzer septal occluder (mean device size, 31.4 3 mm). Patients were
selected by transesophageal echocardiography. The mean ASD dimension was 25.3
3.7 mm and 33 (73%) patients had deficient anterior rim. Specific procedural details
included the use of 13 or 14 Fr introducer sheaths and the right upper pulmonary vein
approach if the conventional approach failed. There were two procedural failures, with
device embolization in both (surgical retrieval in one, catheter retrieval in one). During
follow-up (3–30 months; median, 16 months), one patient (59 years) with previous atrial
flutter had pulmonary embolism and was managed with anticoagulation. Two patients
developed symptomatic atrial flutter. Fluoroscopy time was 31.6 19.5 min for the first
22 cases and 19.6 11.4 min for the rest (P 0.04). Transcatheter closure of large ASDs
is technically feasible but careful long-term follow-up is needed to document its safety.
Cathet Cardiovasc Intervent 2003;59:522–527. © 2003 Wiley-Liss, Inc.
Key words: congenital heart disease; catheter interventions
INTRODUCTION
The atrial septal defect (ASD) represents about 10%
of all congenital cardiac anomalies [1]. The closure of
ASD with large left-to-right shunt is considered nec-
essary to prevent the development of pulmonary vas-
cular disease and atrial arrhythmias and the benefit has
been shown even in patients older than 40 years [2].
The development of devices for transcatheter closure
of ASD located in the fossa ovalis region represents an
important advance in catheter-based management of
congenital heart disease. Adequate rim of septal tissue
around the defect is considered to be necessary to hold
the device in position. Previous reports have demon-
strated that transcatheter closure is safe and easy to use
with a high success rate in small to moderate-sized
defects [3– 6]. Defects that stretch to dimensions of 25
mm or more are extremely difficult to close with all
available devices other than Amplatzer septal occluder
(ASO; AGA Medical, MN) and it can be technically
challenging even with ASO. Because of its unique
self-centering design, the ASO requires less atrial sep-
tal tissue around the ASD for its stability. We report
our experience in the closure of large defects that
stretched to 25 mm, using ASO. The report will
focus on patient selection, technique, and immediate
and short-term follow-up results.
MATERIALS AND METHODS
Study Design
This was a retrospective study. We reviewed the
records of all patients who underwent transcatheter clo-
sure of ASD at our institution between June 1999 and
September 2002. Patients with large ASD, defined as
those defects with a balloon-stretched diameter of at least
25 mm, were chosen for this report.
Patient Population
Patients referred for ASD closure were screened for
suitability for closure with ASO. After evaluation by
transthoracic echocardiography (TTE), all patients un-
derwent transesophageal echocardiography (TEE) for
complete assessment of the defect, its margins, pulmo-
nary venous drainage and for additional defects. Patients
Department of Pediatric Cardiology, Amrita Institute of Medical
Sciences, Kochi, Kerala, India
*Correspondence to: Raman Krishna Kumar, Amrita Institute of Med-
ical Sciences and Research Centre, Elamakkara PO, Kochi, 682026,
Kerala, India. E-mail: rkrishnakumar@aimshospital.org
Received 7 November 2002; Revision accepted 8 April 2003
DOI 10.1002/ccd.10575
Published online in Wiley InterScience (www.interscience.wiley.com).
Catheterization and Cardiovascular Interventions 59:522–527 (2003)
© 2003 Wiley-Liss, Inc.